Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, double-dummy, active-controlled,
non-inferiority clinical study in women aged 35 to 42 years. This study will investigate the
safety and efficacy of Progesterone-IBSA to support euploid embryo blastocyst implantation
and early pregnancy after frozen embryo transfer (FET) in a modified natural cycle as a
treatment for infertile women. Subjects will be randomized to receive either active
Progesterone-IBSA or Crinone 8% for luteal and early pregnancy support and these two groups
will be compared.